Review



wrist-worn actigraphy device ax3  (Axivity Ltd)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Axivity Ltd wrist-worn actigraphy device ax3
    A Participants are requested to collect saliva, which will be further processed for RNA isolation and quantification of gene expression via RT-PCR or NanoString Ⓡ methodologies depending on the quality and amount of available RNA per sample. Additional data will be collected for activity tracking using a wrist-worn <t>actigraphy</t> device and questionnaires. (**): Actigraphy and questionnaire data will be collected from all patients and controls. From a subset of patients with PD (N = 20 in total) ambulatory polysomnography (PSG level 2) will be carried out. B Saliva sampling is carried out according to the proposed scheme. Participants from both the control and the PD group will be advised to collect saliva every 4 hours, during their active/awake hours, across two consecutive days, by their attending physician during the introductory session. The icons used in the figure were sourced from Flaticon ( https://www.flaticon.com/ ), and modified for the better representation.
    Wrist Worn Actigraphy Device Ax3, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wrist-worn+actigraphy+device+ax3/wrist+worn+actigraphy+device+ax3/pmc11259294-158-11-14
    Average 90 stars, based on 1 article reviews
    wrist-worn actigraphy device ax3 - by Bioz Stars, 2026-10
    90/100 stars

    Images

    1) Product Images from "Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol"

    Article Title: Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol

    Journal: PLOS ONE

    doi: 10.1371/journal.pone.0305712

    A Participants are requested to collect saliva, which will be further processed for RNA isolation and quantification of gene expression via RT-PCR or NanoString Ⓡ methodologies depending on the quality and amount of available RNA per sample. Additional data will be collected for activity tracking using a wrist-worn actigraphy device and questionnaires. (**): Actigraphy and questionnaire data will be collected from all patients and controls. From a subset of patients with PD (N = 20 in total) ambulatory polysomnography (PSG level 2) will be carried out. B Saliva sampling is carried out according to the proposed scheme. Participants from both the control and the PD group will be advised to collect saliva every 4 hours, during their active/awake hours, across two consecutive days, by their attending physician during the introductory session. The icons used in the figure were sourced from Flaticon ( https://www.flaticon.com/ ), and modified for the better representation.
    Figure Legend Snippet: A Participants are requested to collect saliva, which will be further processed for RNA isolation and quantification of gene expression via RT-PCR or NanoString Ⓡ methodologies depending on the quality and amount of available RNA per sample. Additional data will be collected for activity tracking using a wrist-worn actigraphy device and questionnaires. (**): Actigraphy and questionnaire data will be collected from all patients and controls. From a subset of patients with PD (N = 20 in total) ambulatory polysomnography (PSG level 2) will be carried out. B Saliva sampling is carried out according to the proposed scheme. Participants from both the control and the PD group will be advised to collect saliva every 4 hours, during their active/awake hours, across two consecutive days, by their attending physician during the introductory session. The icons used in the figure were sourced from Flaticon ( https://www.flaticon.com/ ), and modified for the better representation.

    Techniques Used: Isolation, Expressing, Reverse Transcription Polymerase Chain Reaction, Activity Assay, Sampling, Control, Modification

    Related Articles

    Control:

    Article Title: Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol
    Article Snippet: Upon recruitment patients and control subjects will be provided a wrist-worn actigraphy device (AX3, Axivity) which will be used to track resting and activity cycles.

    Article Title: Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
    Article Snippet: A wrist-worn actigraphy device (AX3 axivity device https://axivity.com/product/ax3 ) was used to measure physical activity, sleep, while iPad applications including digital symbol substitution, spatial working memory, and finger tapping tests were used to measure cognition and motor function (19).

    Activity Assay:

    Article Title: Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol
    Article Snippet: Upon recruitment patients and control subjects will be provided a wrist-worn actigraphy device (AX3, Axivity) which will be used to track resting and activity cycles.

    Article Title: Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
    Article Snippet: A wrist-worn actigraphy device (AX3 axivity device https://axivity.com/product/ax3 ) was used to measure physical activity, sleep, while iPad applications including digital symbol substitution, spatial working memory, and finger tapping tests were used to measure cognition and motor function (19).

    Isolation:

    Article Title: Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol
    Article Snippet: Upon recruitment patients and control subjects will be provided a wrist-worn actigraphy device (AX3, Axivity) which will be used to track resting and activity cycles.

    Article Title: Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
    Article Snippet: A wrist-worn actigraphy device (AX3 axivity device https://axivity.com/product/ax3 ) was used to measure physical activity, sleep, while iPad applications including digital symbol substitution, spatial working memory, and finger tapping tests were used to measure cognition and motor function (19).

    Expressing:

    Article Title: Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol
    Article Snippet: Upon recruitment patients and control subjects will be provided a wrist-worn actigraphy device (AX3, Axivity) which will be used to track resting and activity cycles.

    Article Title: Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
    Article Snippet: A wrist-worn actigraphy device (AX3 axivity device https://axivity.com/product/ax3 ) was used to measure physical activity, sleep, while iPad applications including digital symbol substitution, spatial working memory, and finger tapping tests were used to measure cognition and motor function (19).

    Reverse Transcription Polymerase Chain Reaction:

    Article Title: Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol
    Article Snippet: Upon recruitment patients and control subjects will be provided a wrist-worn actigraphy device (AX3, Axivity) which will be used to track resting and activity cycles.

    Article Title: Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
    Article Snippet: A wrist-worn actigraphy device (AX3 axivity device https://axivity.com/product/ax3 ) was used to measure physical activity, sleep, while iPad applications including digital symbol substitution, spatial working memory, and finger tapping tests were used to measure cognition and motor function (19).

    Sampling:

    Article Title: Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol
    Article Snippet: Upon recruitment patients and control subjects will be provided a wrist-worn actigraphy device (AX3, Axivity) which will be used to track resting and activity cycles.

    Article Title: Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
    Article Snippet: A wrist-worn actigraphy device (AX3 axivity device https://axivity.com/product/ax3 ) was used to measure physical activity, sleep, while iPad applications including digital symbol substitution, spatial working memory, and finger tapping tests were used to measure cognition and motor function (19).

    Modification:

    Article Title: Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol
    Article Snippet: Upon recruitment patients and control subjects will be provided a wrist-worn actigraphy device (AX3, Axivity) which will be used to track resting and activity cycles.

    Article Title: Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia
    Article Snippet: A wrist-worn actigraphy device (AX3 axivity device https://axivity.com/product/ax3 ) was used to measure physical activity, sleep, while iPad applications including digital symbol substitution, spatial working memory, and finger tapping tests were used to measure cognition and motor function (19).



    Similar Products

    wrist-worn actigraphy device ax3  (Axivity Ltd)
    90
    Axivity Ltd wrist-worn actigraphy device ax3
    A Participants are requested to collect saliva, which will be further processed for RNA isolation and quantification of gene expression via RT-PCR or NanoString Ⓡ methodologies depending on the quality and amount of available RNA per sample. Additional data will be collected for activity tracking using a wrist-worn <t>actigraphy</t> device and questionnaires. (**): Actigraphy and questionnaire data will be collected from all patients and controls. From a subset of patients with PD (N = 20 in total) ambulatory polysomnography (PSG level 2) will be carried out. B Saliva sampling is carried out according to the proposed scheme. Participants from both the control and the PD group will be advised to collect saliva every 4 hours, during their active/awake hours, across two consecutive days, by their attending physician during the introductory session. The icons used in the figure were sourced from Flaticon ( https://www.flaticon.com/ ), and modified for the better representation.
    Wrist Worn Actigraphy Device Ax3, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/wrist-worn+actigraphy+device+ax3/wrist+worn+actigraphy+device+ax3/pmc11259294-158-11-14
    Average 90 stars, based on 1 article reviews
    wrist-worn actigraphy device ax3 - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    A Participants are requested to collect saliva, which will be further processed for RNA isolation and quantification of gene expression via RT-PCR or NanoString Ⓡ methodologies depending on the quality and amount of available RNA per sample. Additional data will be collected for activity tracking using a wrist-worn actigraphy device and questionnaires. (**): Actigraphy and questionnaire data will be collected from all patients and controls. From a subset of patients with PD (N = 20 in total) ambulatory polysomnography (PSG level 2) will be carried out. B Saliva sampling is carried out according to the proposed scheme. Participants from both the control and the PD group will be advised to collect saliva every 4 hours, during their active/awake hours, across two consecutive days, by their attending physician during the introductory session. The icons used in the figure were sourced from Flaticon ( https://www.flaticon.com/ ), and modified for the better representation.

    Journal: PLOS ONE

    Article Title: Molecular characterization of the circadian clock in patients with Parkinson’s disease–CLOCK4PD Study protocol

    doi: 10.1371/journal.pone.0305712

    Figure Lengend Snippet: A Participants are requested to collect saliva, which will be further processed for RNA isolation and quantification of gene expression via RT-PCR or NanoString Ⓡ methodologies depending on the quality and amount of available RNA per sample. Additional data will be collected for activity tracking using a wrist-worn actigraphy device and questionnaires. (**): Actigraphy and questionnaire data will be collected from all patients and controls. From a subset of patients with PD (N = 20 in total) ambulatory polysomnography (PSG level 2) will be carried out. B Saliva sampling is carried out according to the proposed scheme. Participants from both the control and the PD group will be advised to collect saliva every 4 hours, during their active/awake hours, across two consecutive days, by their attending physician during the introductory session. The icons used in the figure were sourced from Flaticon ( https://www.flaticon.com/ ), and modified for the better representation.

    Article Snippet: Upon recruitment patients and control subjects will be provided a wrist-worn actigraphy device (AX3, Axivity) which will be used to track resting and activity cycles.

    Techniques: Isolation, Expressing, Reverse Transcription Polymerase Chain Reaction, Activity Assay, Sampling, Control, Modification